Need help? Text us and our team of experts will reply in minutes +00 00 00000
Blend
The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV into a single formulation studied for its potential influence on molecular signaling and systemic regulation. In laboratory and preclinical models, these peptides have been investigated for their effects on matrix remodeling, angiogenesis, cytokine modulation, and extracellular matrix activity. Together, they provide a platform for exploring synergistic pathways in molecular dynamics, immune signaling, and vascular biology.
The KLOW Blend draws on several decades of peptide research. GHK-Cu, first identified in biological plasma samples in the 1970s, has been studied for gene expression and matrix signaling. BPC-157, synthesized in the 1990s as a gastric protein fragment analog, has been explored for angiogenic and structural processes. TB-500, derived from thymosin beta-4 research in the 1960s, has been examined for angiogenesis and molecular migration. KPV, a C-terminal fragment of α-MSH, has been evaluated for cytokine-modulating and immunomodulatory activity. Collectively, these peptides represent areas of ongoing investigation into experimental biology, vascular pathways, and immune signaling. The KLOW Blend is intended for research use only.
CAS #: 49557-75-7
Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
CAS #: 137525-51-0
Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
CAS #: 77591-33-4
Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963.5 g/mol
PubChem ID: 16132321
CAS #: 3061-91-6
Formula: C₁₆H₂₈N₆O₅
Molecular Weight: 388.4 g/mol
PubChem ID: 16129619
The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, epithelial, and systemic models. Research highlights activity in collagen formation, extracellular matrix remodeling, angiogenesis, molecular migration, and cytokine modulation. The inclusion of KPV further supports immune signaling and cytokine-modulating pathways, expanding the experimental scope of this blend in preclinical settings.
Key Areas of Research:
Structural: Collagen, matrix, connective signaling
Vascular: Angiogenesis, nitric oxide, remodeling
Epithelial: Migration, matrix signaling, follicle dynamics
Systemic: Cytokine modulation, immune signaling, pathway dynamics
Together, these findings suggest broad experimental potential for the KLOW Blend across multiple biological pathways. By combining structural support, vascular and epithelial activity, and immune signaling, the KLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and systemic resilience in laboratory settings.
STEP 1
Precision Lyophilization
STEP 2
Verified Purity
STEP 3
Same-Day Fulfillment
Orders dispatched same-day from our U.S. facility.
Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.
Products from Raw Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
